Balyasny Asset Management LLC Recursion Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$7.35 - $10.05 $1.8 Million - $2.46 Million
245,210 New
245,210 $1.84 Million
Q2 2023

Aug 14, 2023
BUY
$4.56 - $9.94 $3.34 Million - $7.29 Million
733,334 Added 1094.76%
800,320 $5.98 Million
Q1 2023

May 15, 2023
SELL
$6.42 - $9.64 $541,546 - $813,162
-84,353 Reduced 55.74%
66,986 $446,000
Q4 2022

Feb 14, 2023
BUY
$7.16 - $12.7 $1.08 Million - $1.92 Million
151,339 New
151,339 $1.17 Million

Others Institutions Holding RXRX

# of Institutions
286
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.41B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email